• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?冠状病毒病（COVID-19）大流行期间的抗病毒治疗：在缺乏充分证据的情况下治疗患者是否合适？
Can J Hosp Pharm. 2020 Mar-Apr;73(2):167-170.
2
Antiviral therapy of coronavirus disease 2019 (COVID-19).2019 冠状病毒病（COVID-19）的抗病毒治疗。
J Formos Med Assoc. 2024 Jan;123 Suppl 1:S47-S54. doi: 10.1016/j.jfma.2023.08.029. Epub 2023 Sep 2.
3
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
4
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.关于在疫情爆发情况下治疗新型冠状病毒（SARS-CoV-2）的新兴治疗和预防策略的循证系统评价。
J Basic Clin Physiol Pharmacol. 2020 Sep 14;31(6):jbcpp-2020-0113. doi: 10.1515/jbcpp-2020-0113.
5
Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea.韩国轻度至中度 2019 冠状病毒病患者的治疗选择。
J Korean Med Sci. 2022 Dec 12;37(48):e352. doi: 10.3346/jkms.2022.37.e352.
6
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的疗效。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547. doi: 10.26355/eurrev_202004_21038.
7
Antiviral therapy in management of COVID-19: a systematic review on current evidence.COVID-19管理中的抗病毒治疗：对当前证据的系统评价
Arch Acad Emerg Med. 2020 Apr 6;8(1):e45. eCollection 2020.
8
COVID-19 diagnosis and management: a comprehensive review.COVID-19 的诊断与管理：全面综述。
J Intern Med. 2020 Aug;288(2):192-206. doi: 10.1111/joim.13091. Epub 2020 May 13.
9
Recent progress of antiviral therapy for coronavirus disease 2019.新型冠状病毒病抗病毒治疗的最新进展。
Eur J Pharmacol. 2021 Jan 5;890:173646. doi: 10.1016/j.ejphar.2020.173646. Epub 2020 Oct 24.
10
Understanding the Role of Corona Virus based on Current Scientific Evidence - A Review with Emerging Importance in Pandemic.基于当前科学证据理解冠状病毒的作用——大流行中日益重要的综述
Recent Pat Antiinfect Drug Discov. 2020;15(2):89-103. doi: 10.2174/1574891X15999200918144833.

引用本文的文献

1
Response to: Regarding the Article: A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19.对以下内容的回应：关于文章《一种降低COVID-19门诊患者住院/死亡风险的多模式策略》
Arch Med Res. 2022 Jul;53(5):541-542. doi: 10.1016/j.arcmed.2022.05.002. Epub 2022 May 10.
2
Ethical Dimensions of Public Health Actions and Policies With Special Focus on COVID-19.公共卫生行动和政策的伦理维度，特别关注 COVID-19。
Front Public Health. 2021 Aug 2;9:649918. doi: 10.3389/fpubh.2021.649918. eCollection 2021.

本文引用的文献

1
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].羟氯喹治疗中度新型冠状病毒肺炎患者的一项试点研究
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03.
2
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.2019年冠状病毒病大流行期间羟氯喹短缺对系统性红斑狼疮患者的潜在后果
J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.
3
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.仓促下结论？有关羟氯喹治疗 COVID-19 的快速报告和结果传播及其后果。
Ann Intern Med. 2020 Jun 16;172(12):819-821. doi: 10.7326/M20-1223. Epub 2020 Mar 30.
4
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
5
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
6
How the CIOMS guidelines contribute to fair inclusion of pregnant women in research.《CIOMS 指南如何促进公平纳入孕妇参与研究》。
Bioethics. 2019 Mar;33(3):367-373. doi: 10.1111/bioe.12520. Epub 2018 Oct 20.
7
Social value, clinical equipoise, and research in a public health emergency.社会价值、临床平衡和公共卫生紧急情况下的研究。
Bioethics. 2019 Mar;33(3):326-334. doi: 10.1111/bioe.12467. Epub 2018 Jul 27.
8
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.氯喹治疗增强基孔肯雅热病毒感染的矛盾效应。
Viruses. 2018 May 17;10(5):268. doi: 10.3390/v10050268.
9
Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach.将孕妇合理纳入临床试验：一种科学与伦理相结合的方法。
Trials. 2018 Jan 29;19(1):78. doi: 10.1186/s13063-017-2402-9.
10
Ethics of trial drug use: to give or not to give?试验性药物使用的伦理：给予还是不给予？
BEOnline. 2016;3(2):22-40. doi: 10.20541/beonline.2016.0007. Epub 2016 Nov 22.

Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?

出版信息

Can J Hosp Pharm. 2020 Mar-Apr;73(2):167-170.

PMID:32536693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269638/
Abstract
摘要